SANTILLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 9.827
EU - Europa 6.709
AS - Asia 6.377
SA - Sud America 803
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 23.828
Nazione #
US - Stati Uniti d'America 9.608
SG - Singapore 2.639
CN - Cina 1.673
RU - Federazione Russa 1.419
IE - Irlanda 953
IT - Italia 938
UA - Ucraina 787
TR - Turchia 702
SE - Svezia 698
BR - Brasile 651
VN - Vietnam 602
GB - Regno Unito 566
DE - Germania 412
FR - Francia 404
IN - India 266
FI - Finlandia 250
HK - Hong Kong 115
CA - Canada 111
BD - Bangladesh 72
MX - Messico 72
AR - Argentina 69
PL - Polonia 65
JP - Giappone 51
NL - Olanda 49
IQ - Iraq 42
ZA - Sudafrica 35
AT - Austria 34
ES - Italia 29
ID - Indonesia 28
KR - Corea 25
PK - Pakistan 23
CZ - Repubblica Ceca 18
EC - Ecuador 17
VE - Venezuela 17
BE - Belgio 16
MA - Marocco 16
SA - Arabia Saudita 14
AZ - Azerbaigian 13
CL - Cile 13
LT - Lituania 12
UZ - Uzbekistan 12
EU - Europa 11
IR - Iran 11
AL - Albania 10
CO - Colombia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
PH - Filippine 9
DZ - Algeria 8
PY - Paraguay 8
RO - Romania 8
EG - Egitto 7
JM - Giamaica 7
LB - Libano 7
PE - Perù 7
NG - Nigeria 6
OM - Oman 6
QA - Qatar 6
UY - Uruguay 6
CH - Svizzera 5
ET - Etiopia 5
KE - Kenya 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
DK - Danimarca 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
NI - Nicaragua 4
NP - Nepal 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BG - Bulgaria 3
BZ - Belize 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
KH - Cambogia 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
Totale 23.814
Città #
Singapore 2.026
San Jose 1.198
Chandler 1.086
Jacksonville 959
Dublin 939
Ashburn 850
Dallas 530
Beijing 448
Princeton 383
Southend 370
Izmir 335
Los Angeles 257
Nanjing 235
Santa Clara 230
Council Bluffs 225
Ho Chi Minh City 206
Dearborn 205
The Dalles 192
Wilmington 186
New York 183
Cambridge 159
Ann Arbor 144
Hanoi 141
Altamura 134
Chieti 115
Hong Kong 103
Moscow 103
Munich 103
Nanchang 99
Tongling 99
Boardman 90
Buffalo 86
Pescara 79
São Paulo 69
Washington 66
Orem 62
Helsinki 61
Redondo Beach 57
Montreal 50
Shenyang 49
Brooklyn 48
Hebei 48
Kunming 47
Tokyo 46
Woodbridge 44
Tianjin 42
Rome 38
Warsaw 38
Denver 33
Turku 33
Chennai 32
Changsha 31
Jiaxing 31
Stockholm 31
Frankfurt am Main 30
Grevenbroich 30
Milan 30
Seattle 30
Hefei 29
Mexico City 29
Norwalk 29
London 28
Poplar 28
Augusta 27
Chicago 27
Johannesburg 27
Atlanta 26
Toronto 26
Amsterdam 23
Seoul 23
Da Nang 22
Nuremberg 22
Manchester 20
Ankara 19
Hangzhou 19
Houston 19
San Francisco 19
Boston 18
Dong Ket 18
Jinan 18
Phoenix 18
Shanghai 18
Changchun 17
Lanzhou 17
Mumbai 17
San Mateo 17
Brussels 16
Falls Church 15
Rio de Janeiro 15
Vienna 15
Baghdad 14
Belo Horizonte 14
Brno 14
Guangzhou 14
Haiphong 14
Querétaro 14
St Louis 13
Baku 12
Brasília 12
Paris 12
Totale 14.388
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 830
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 185
Pentraxin 3 and platelet activation in obese patients after gastric banding 180
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 175
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 168
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 167
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 165
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 165
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 163
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 158
Role of growth factors in the development of diabetic complications 158
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 155
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 155
Determinants of platelet activation in hypertensives with microalbuminuria. 154
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 154
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 149
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 147
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 145
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 145
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 144
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 144
Neurocognitive impairment and suicide risk among prison inmates 144
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 143
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 143
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 141
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 141
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 141
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 141
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 141
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 141
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 140
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 139
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Platelets and Diabetes 138
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 138
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 137
COVID-19 and RAS: Unravelling an Unclear Relationship 136
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 136
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 135
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 135
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 134
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 134
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 133
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 133
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 133
Insulin resistance as a determinant of platelet activation in obese women. 132
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 132
Coagulation and infective endocarditis: sooner or later 132
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 132
Platelet activation in obesity and metabolic syndrome. 131
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 131
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 131
Aspirin, platelets, and cancer: The point of view of the internist. 131
Platelets and diabetes mellitus 131
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 130
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 129
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 129
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 129
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 129
The role of antileukotrienes in the treatment of asthma. 128
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 128
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 128
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 127
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 127
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 126
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 126
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 125
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 125
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 124
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 124
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 124
Determinants of platelet activation in hypertensives with microalbuminuria. 123
The role of nitric oxide in the development of diabetic angiopathy. 122
Soluble RAGE in type 2 diabetes: association with oxidative stress. 122
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 122
Association between PAI-1 and Oxidative Stress in Android Obesity 121
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 121
Soluble forms of RAGE in internal medicine. 120
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 119
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study 118
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 118
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 117
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 117
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 116
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 116
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 116
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 116
Atherothrombotic disease and the metabolic syndrome. 115
I biomarcatori nella stratificazione del rischio. Cosa aggiungono nella gestione del paziente. 115
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 113
Correlation between Migraine Severity and Cholesterol Levels 113
Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study 112
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 112
The left atrial appendage: from embryology to prevention of thromboembolism 112
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 112
Aspirin as antiplatelet agent in diabetes. PROS-. 112
Totale 14.210
Categoria #
all - tutte 99.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.728 242 703 577 88 92 172 141 171 344 174 448 576
2025/20269.074 647 336 905 1.079 897 459 1.440 469 1.557 813 394 78
Totale 24.963